Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
180 | 52477 | 35.2 | 78% |
Classes in level above (level 4) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
0 | 3633673 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//MED |
Classes in level below (level 2) |
ID, lev. below |
Publications | Label for level below |
---|---|---|
63 | 28284 | OPHTHALMOLOGY//RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES//AGE RELATED MACULAR DEGENERATION |
222 | 19941 | LYMPHANGIOGENESIS//ANGIOGENESIS//ENDOSTATIN |
2636 | 3017 | RETINOPATHY OF PREMATURITY//NORRIE DISEASE//COATS DISEASE |
3817 | 623 | PEDF//PIGMENT EPITHELIUM DERIVED FACTOR//PIGMENT EPITHELIUM DERIVED FACTOR PEDF |
3823 | 612 | MASPIN//RARRES3//TIG3 |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | OPHTHALMOLOGY | WoS category | 3583 | 13% | 49% | 25556 |
2 | RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES | Journal | 2205 | 58% | 5% | 2573 |
3 | OPHTHALMOL | Address | 2115 | 15% | 25% | 13310 |
4 | AGE RELATED MACULAR DEGENERATION | Author keyword | 1738 | 62% | 3% | 1797 |
5 | DIABETIC RETINOPATHY | Author keyword | 1128 | 50% | 3% | 1614 |
6 | RANIBIZUMAB | Author keyword | 1070 | 84% | 1% | 590 |
7 | CHOROIDAL NEOVASCULARIZATION | Author keyword | 888 | 71% | 1% | 726 |
8 | RETINOPATHY OF PREMATURITY | Author keyword | 866 | 75% | 1% | 633 |
9 | MACULAR HOLE | Author keyword | 834 | 85% | 1% | 435 |
10 | LYMPHANGIOGENESIS | Author keyword | 832 | 71% | 1% | 678 |
Web of Science journal categories |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | Ophthalmology | 3583 | 13% | 49% | 25556 |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | AGE RELATED MACULAR DEGENERATION | 1738 | 62% | 3% | 1797 | Search AGE+RELATED+MACULAR+DEGENERATION | Search AGE+RELATED+MACULAR+DEGENERATION |
2 | DIABETIC RETINOPATHY | 1128 | 50% | 3% | 1614 | Search DIABETIC+RETINOPATHY | Search DIABETIC+RETINOPATHY |
3 | RANIBIZUMAB | 1070 | 84% | 1% | 590 | Search RANIBIZUMAB | Search RANIBIZUMAB |
4 | CHOROIDAL NEOVASCULARIZATION | 888 | 71% | 1% | 726 | Search CHOROIDAL+NEOVASCULARIZATION | Search CHOROIDAL+NEOVASCULARIZATION |
5 | RETINOPATHY OF PREMATURITY | 866 | 75% | 1% | 633 | Search RETINOPATHY+OF+PREMATURITY | Search RETINOPATHY+OF+PREMATURITY |
6 | MACULAR HOLE | 834 | 85% | 1% | 435 | Search MACULAR+HOLE | Search MACULAR+HOLE |
7 | LYMPHANGIOGENESIS | 832 | 71% | 1% | 678 | Search LYMPHANGIOGENESIS | Search LYMPHANGIOGENESIS |
8 | ANGIOGENESIS | 827 | 18% | 8% | 4287 | Search ANGIOGENESIS | Search ANGIOGENESIS |
9 | VITRECTOMY | 777 | 60% | 2% | 859 | Search VITRECTOMY | Search VITRECTOMY |
10 | BEVACIZUMAB | 591 | 36% | 2% | 1304 | Search BEVACIZUMAB | Search BEVACIZUMAB |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | ENDOTHELIAL GROWTH FACTOR | 1632 | 20% | 14% | 7180 |
2 | MACULAR DEGENERATION | 1552 | 37% | 6% | 3303 |
3 | RANIBIZUMAB | 1534 | 76% | 2% | 1060 |
4 | VERTEPORFIN | 1237 | 76% | 2% | 867 |
5 | PARS PLANA VITRECTOMY | 1162 | 69% | 2% | 1004 |
6 | VITRECTOMY | 1109 | 59% | 2% | 1255 |
7 | CHOROIDAL NEOVASCULARIZATION | 1105 | 61% | 2% | 1159 |
8 | INTERNAL LIMITING MEMBRANE | 1020 | 85% | 1% | 543 |
9 | ANGIOGENESIS | 1007 | 15% | 11% | 6020 |
10 | AVASTIN | 985 | 84% | 1% | 545 |
Journals |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES | 2205 | 58% | 5% | 2573 |
2 | AMERICAN JOURNAL OF OPHTHALMOLOGY | 442 | 20% | 4% | 1979 |
3 | GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY | 437 | 26% | 3% | 1443 |
4 | OPHTHALMOLOGY | 377 | 18% | 4% | 1884 |
5 | INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 343 | 13% | 5% | 2381 |
6 | BRITISH JOURNAL OF OPHTHALMOLOGY | 282 | 17% | 3% | 1507 |
7 | ARCHIVES OF OPHTHALMOLOGY | 266 | 17% | 3% | 1414 |
8 | EYE | 204 | 20% | 2% | 896 |
9 | OPHTHALMOLOGICA | 159 | 24% | 1% | 591 |
10 | OPHTHALMIC SURGERY LASERS & IMAGING | 151 | 35% | 1% | 355 |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
The biology of VEGF and its receptors | 2003 | 4229 | 125 | 64% |
Molecular mechanisms and clinical applications of angiogenesis | 2011 | 884 | 92 | 49% |
Angiogenesis in cancer and other diseases | 2000 | 4324 | 62 | 47% |
The biology of vascular endothelial growth factor | 1997 | 2889 | 215 | 72% |
VEGF receptor signalling - in control of vascular function | 2006 | 1204 | 132 | 65% |
Seeing through VEGF: innate and adaptive immunity in pathological angiogenesis in the eye | 2015 | 5 | 86 | 79% |
Normalization of tumor vasculature: An emerging concept in antiangiogenic therapy | 2005 | 2198 | 44 | 43% |
Molecular origins of cancer: Tumor angiogenesis | 2008 | 964 | 91 | 45% |
Vascular endothelial growth factor: Basic science and clinical progress | 2004 | 1660 | 396 | 53% |
Vascular endothelial growth factor (VEGF) and its receptors | 1999 | 2244 | 173 | 72% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | OPHTHALMOL | 2115 | 15% | 25% | 13310 |
2 | OPHTHALMOL VISUAL SCI | 336 | 16% | 3.7% | 1949 |
3 | MOL CANC BIOL | 137 | 46% | 0.4% | 219 |
4 | RETINA SERV | 130 | 45% | 0.4% | 221 |
5 | LUESTHER T MERTZ RETINAL | 115 | 63% | 0.2% | 117 |
6 | EYE | 113 | 16% | 1.3% | 671 |
7 | VITREORETINAL SURG | 110 | 56% | 0.3% | 133 |
8 | MACULAR DEGENERAT | 96 | 81% | 0.1% | 57 |
9 | RETINA | 90 | 47% | 0.3% | 141 |
10 | AUGENKLIN | 76 | 15% | 0.9% | 458 |
Related classes at same level (level 3) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000004201 | RETINA//ELECTRIC FISH//ELECTRIC ORGAN DISCHARGE |
2 | 0.0000003384 | OPHTHALMOLOGY//JOURNAL OF CATARACT AND REFRACTIVE SURGERY//OPHTHALMOL |
3 | 0.0000002474 | TIGHT JUNCTION//CLAUDIN//OCCLUDIN |
4 | 0.0000002337 | HEPARANASE//MIDKINE//HEPARAN SULFATE |
5 | 0.0000002043 | BEHCETS DISEASE//WEGENERS GRANULOMATOSIS//GIANT CELL ARTERITIS |
6 | 0.0000001995 | CD44//HYALURONAN//INTEGRIN |
7 | 0.0000001904 | NOONAN SYNDROME//COSTELLO SYNDROME//PROTEIN TYROSINE PHOSPHATASE |
8 | 0.0000001869 | ERYTHROPOIETIN//ACUTE MOUNTAIN SICKNESS//HYPOXIA |
9 | 0.0000001753 | CELL & TISSUE ENGINEERING//MESENCHYMAL STEM CELLS//ENDOTHELIAL PROGENITOR CELLS |
10 | 0.0000001642 | CARCINOMA RENAL CELL//ANGIOMYOLIPOMA//TUBEROUS SCLEROSIS |